Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flaherty

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Plos One|March 17, 2023
Development of an ectopic huLiver model for Plasmodium liver stage infectionGabriela Samayoa-Reyes, Siobhan M Flaherty, Kristina S Wickham, et al.
Nurse Leader|March 6, 2026
The Fall TIPS (Tailoring Interventions for Patient Safety) Program: A Collaboration to End the Persistent Problem of Patient FallsPatricia C Dykes, Jason S Adelman, Lois Alfieri, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 30, 2020
Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cureSelvi Srinivasan, Debashish Roy, Thomas E J Chavas, et al.
Viruses|July 2, 2021
Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody CocktailArnaud C Drouin, Marc W Theberge, Sharon Y Liu, et al.
Ebiomedicine|May 13, 2025
An ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primatesBeryl B Cummings, Page R Bouchard, Mark N Milton, et al.
Lancet (London, England)|May 18, 2025
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studiesBeryl B Cummings, Mark P Joing, Page R Bouchard, et al.
Cancer Discovery|May 21, 2017
Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal CancersCarl U Bialucha, Scott D Collins, Xiao Li, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Plos One|March 17, 2023
Development of an ectopic huLiver model for Plasmodium liver stage infectionGabriela Samayoa-Reyes, Siobhan M Flaherty, Kristina S Wickham, et al.
Nurse Leader|March 6, 2026
The Fall TIPS (Tailoring Interventions for Patient Safety) Program: A Collaboration to End the Persistent Problem of Patient FallsPatricia C Dykes, Jason S Adelman, Lois Alfieri, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 30, 2020
Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cureSelvi Srinivasan, Debashish Roy, Thomas E J Chavas, et al.
Viruses|July 2, 2021
Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody CocktailArnaud C Drouin, Marc W Theberge, Sharon Y Liu, et al.
Ebiomedicine|May 13, 2025
An ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primatesBeryl B Cummings, Page R Bouchard, Mark N Milton, et al.
Lancet (London, England)|May 18, 2025
Safety and efficacy of a novel ANGPTL4 inhibitory antibody for lipid lowering: results from phase 1 and phase 1b/2a clinical studiesBeryl B Cummings, Mark P Joing, Page R Bouchard, et al.
Cancer Discovery|May 21, 2017
Discovery and Optimization of HKT288, a Cadherin-6-Targeting ADC for the Treatment of Ovarian and Renal CancersCarl U Bialucha, Scott D Collins, Xiao Li, et al.
Pageof 17